221221-03-0

Basic information

• Product Name: Benzoic acid, 3-chloro-2,4-difluoro-5-nitro-
• Synonyms: 5-nitro-3-chloro-2,4-difluorobenzoic acid;Benzoic acid,3-chloro-2,4-difluoro-5-nitro;3-chloro-2,4-difluoro-5-nitro-benzoic acid
• CAS NO: 221221-03-0
• Molecular Formula: C7H2ClF2NO4
• Molecular Weight: 237.547
• Mol File: 221221-03-0.mol

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-chloro-2,4-difluoro-5-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-chloro-2,4-difluoro-5-nitro-(221221-03-0)
• EPA Substance Registry System: Benzoic acid, 3-chloro-2,4-difluoro-5-nitro-(221221-03-0)

Safety Data

• Hazardous Substances Data: 221221-03-0(Hazardous Substances Data)

Upstream product

• 154257-75-7 2,4-difluoro-3-chlorobenzoic acid 

Downstream Products

• 927430-70-4 3-chloro-2-fluoro-5-nitro-4-(2-trimethylsilanyl-ethylsulfanyl)-benzoic acid 
• 1000162-95-7 C₇H₄ClF₂NO₃ 
• 927430-56-6 3-chloro-2-fluoro-4-methylamino-5-nitro-benzoic acid 
• 1100985-19-0 5-nitro-3-chloro-2,4-difluorobenzoyl chloride 
• 606144-32-5 4-amino-3-chloro-2-fluoro-5-nitro-benzoic acid 

Relevant articles and documents

A practical synthesis of 3-chloro-2,4-difluoro-5-hydroxybenzoic acid

A new and practical synthesis of 3-chloro-2,4-difluoro-5-hydroxybenzoic acid, a key intermediate for preparing antimicrobial 3-quinolinecarboxylic acid drugs, is synthesized from 2,4-difluoro-3-chlororobenzoic acid. The protocol involves nitration, esteri

An efficient synthesis of 2,4-difluoro-3,5-dichlorobenzoic acid

2,4-Difluoro-3,5-dichlorobenzoic acid, as a key intermediate for preparing quinolone-3-carboxylic acids, was synthesised from the commercially available 2,4-difluoro-3-chlorobenzoic acid in excellent yield by a reaction sequence involving nitration, selec

6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor

The present invention relates to a compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutical composition, an anti-HIV

ANTIMICROBIAL QUINOLONES, THEIR COMPOSITIONS AND USES

Compounds of the following formula (I) are effective antimicrobial agents.

N3 alkylated benzimidazole derivatives as MEK inhibitors

Disclosed are compounds of the formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein W, R1, R2, R7, R8, R9 and R10 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals. Also disclosed is a method of using such compounds in the treatment of hyperproliferative diseases in mammals, and pharmaceutical compositions containing such compounds.

Antimicrobial quinolones, their compositions and uses

Compounds having the general structure: which are effective antimicrobial agents.

Antimicrobial quinolones, their compositions and uses

Compounds having the general structure: which are effective antimicrobial agents.

Process for making certain benzoic acid compounds

The subject invention involves processes for making 2,4-difluoro-3-Q1-benzoic acid, wherein Q1 is derived from an electrophilic reagent, comprising the steps of: (a) treating 1-bromo-2,4-difluorobenzene with a strong, non-nucleophilic base; then treating

Antimicrobial quinolones, their compositions and uses

This invention relates to novel antimicrobial compounds of formula; wherein X, R1, R3, R5, R6, and R8 are defined in the claims, and to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically-acceptable salts, hydrates, and biohydrolyzable esters, amides and imides thereof, and to compositions and uses of such compounds. The invention also relates to compounds derived from these compounds having antimicrobial uses.